{"name":"TScan Therapeutics, Inc.","slug":"tscan-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"TSC-200-A0201","genericName":"TSC-200-A0201","slug":"tsc-200-a0201","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"TSC-200-A0201","genericName":"TSC-200-A0201","slug":"tsc-200-a0201","phase":"phase_1","mechanism":"Biologic","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi9AFBVV95cUxNdnBhZDUxVGZKR3VfNGJ1bzFmQ3MtY1lQUy1jeHU2MkwzQnFnMG9nQ0xGcmNRVmxpdVVvN19SQjBrWldXZTYyMTJhNFUxTndRX3hVQ2Vyb1k4QjhuV1NRVnBXd2xrcWNfc0VkY2xlbEdpUWN4Rlpvb25PamhIWmhHWDhpcTdCbGRNajJYamdlX0MtNTJTQWVYRDl3d0lGZXJlMnJKN1RwYm9kdzVfNTl1Z3dzRUdaLVZqY0M4ZVN6TnlJN21zXzI5V29TMVRQN0lOUVltVE1TOGJ3X3A0Mi1BNTNseUh5NzZOb0paTFJfOGItN0Z3?oc=5","date":"2026-04-08","type":"pipeline","source":"GlobeNewswire","summary":"TScan Therapeutics to Participate in the 25th Annual Needham Virtual Healthcare Conference - GlobeNewswire","headline":"TScan Therapeutics to Participate in the 25th Annual Needham Virtual Healthcare Conference","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAFBVV95cUxQbHZpM0hJX1l3LUNtWS1hOXFKUVpVYjVLYk15dUxoeHFOTWtNeEplVHFRUmFVbzZIb3RhbHQ1WUdJTXh4alB6OHh6YVVDVTBoRDdKMXFnQXAtRGJjYXV4dFJxWTliUUpicUtFRjJUaGFDdzJwYms0VnUtTzFYRmdNN1Y4UWdlZnRk?oc=5","date":"2026-03-04","type":"earnings","source":"Yahoo Finance","summary":"TScan Therapeutics, Inc. (TCRX) Reports Q4 Loss, Misses Revenue Estimates - Yahoo Finance","headline":"TScan Therapeutics, Inc. (TCRX) Reports Q4 Loss, Misses Revenue Estimates","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMiiwJBVV95cUxOd19fSlVzTjBoejdSaTFoUWM5cHlLYjh5dm42aW9MdXVZN0pxQkwtdTNPaU1jMmNOQmhJNjNya1BCQXhod3U3VTJSYTNSdHdzcTEzalVEZEJBVnN0dV82ZHo4Sm5wcG11QlA4b3IwaURXQ2xrZ2FFMWN5WXpubWM3N0w4VFY4MjNtaE4xYnAtR1dUNVRGUjBSNEprZWE3R01HM1A3YXRCLUZxZzRyOTU5UFZISFA3dnRXTklBWjdVRlFCcmVQZ0c5MkdSTDZaY05tMGpIVkJJQkVaYVp0RDFEZTZNeTNTR25id2VpZ24xQWF2aTJ5bU5IWl9tUW5iUkpuMVlPOGxZMnNDLUU?oc=5","date":"2026-03-04","type":"earnings","source":"GlobeNewswire","summary":"TScan Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - GlobeNewswire","headline":"TScan Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxPV3NiMjBLRHM3ZFAzNWhpSnZheFQtSlhSeGlwYVQ5TElrSTItTllKbXpjei1ic3hJR2IxVy03TGR6TlZnaGtHS25rSjFzaUdtY3dVRTZYenVVOEE0NlVoTUpTeVE1UXh4SlJHMm94dmt6MllWZHNqQ0dQejNQd01JcC1XbmlmQVIzMTAwZHJMSmpZS081T2IzU3h6RlBYeXh6ZGlsdkxJVk5YQ0NtelFCRk1pQlA3bDQ?oc=5","date":"2026-02-13","type":"pipeline","source":"Benzinga","summary":"12 Health Care Stocks Moving In Friday's After-Market Session - Benzinga","headline":"12 Health Care Stocks Moving In Friday's After-Market Session","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxNbGFOR183QW84SDNIWW12UGNGTWNOclFvWVdWbGIwOUNLa0RZUmk3MnRsdndTV3pIazZJMGppeDBoaWkzZmZVUjNUME10S0JkSmI4MlZxSGdhRmZESlkxYW83a09yUTcySGdNeU8wUWNtYVE0X0NhNGFXeW1UcFBiWERkWVRsVVgzUHRuTjlKTGRlNU5veDh4UDUxYTRJREVZSGNSVkpiYlRaWXctYS1uRklscmR3S1N1MnppTDhYTjJwVkhhNkJkZlhn?oc=5","date":"2026-01-30","type":"deal","source":"finviz.com","summary":"Citi Raises Lexicon Pharmaceuticals (LXRX) Outlook on Strength of Novo Nordisk Partnership Milestones - finviz.com","headline":"Citi Raises Lexicon Pharmaceuticals (LXRX) Outlook on Strength of Novo Nordisk Partnership Milestones","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiwJBVV95cUxQTm9qRFRSdjNtTWdKS0gwMkIwT2R4eGF3OFBnN0tDMHg4MFBYc0tYV0hOYUluUVhieWRLdTktNTNYZjRaQVJ6eEtBV3hYeERtMnV0ZUZZelNDdHZxQk83b08takttQjlDREVFWnVFODJlWTVPU2lCMzFjS1Yxc2FwZTJCZzVVWVFZLXV4NXRJMjNvY2RSMmhvQXdFM0tCVFVEQVRtV1AzT0NlT0pVWktiZkUyV2VaVWFzcE1ZcXlTd1d4QkZEZWFBazgzM1JIVWEwaWlmQ3JqREloZ0puYm5HVUR4SkQ3RTZkTUdSLWJCeWJJd0YzenpUcVZGNGc5c0QtdWhqaDQ2clFrakU?oc=5","date":"2025-12-19","type":"pipeline","source":"Finansavisen","summary":"Smart Money Abandons Single-Asset Risk: Why Platforms Now Command 60% of Pharma Pipelines - Finansavisen","headline":"Smart Money Abandons Single-Asset Risk: Why Platforms Now Command 60% of Pharma Pipelines","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTE9iVUFUYkF6aGt3akxZT0hGaW1LLTVITDlQdFFCYUZkc2IwaDJKSHZpQ1d2VmtPWldraV9yWm9idUZab0xqcWZzdXllQ1BIaF9WUGVxcFJMNWhPakFld2QzRVg2dElTbkZjVjdzcEY3QmtFRG96SzhTT25aMkY?oc=5","date":"2025-12-17","type":"pipeline","source":"Fierce Biotech","summary":"Fierce Biotech Layoff Tracker 2025: Voyager jettisons 30 staffers; Mythic and Areteia shutter - Fierce Biotech","headline":"Fierce Biotech Layoff Tracker 2025: Voyager jettisons 30 staffers; Mythic and Areteia shutter","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFBWWlVGSEJxRHc2UHg5LTJDdXhDODIwT3dVTEtSNzJyTTI4d1VjMjZGSzEtbDljUGVSN1JrQ012bEwyWlFGSkZ3M1FnR3VfMjBDdzVV?oc=5","date":"2025-11-04","type":"pipeline","source":"FirstWord Pharma","summary":"TScan trims 30% of staff, prioritising blood cancers programme over solid tumours - FirstWord Pharma","headline":"TScan trims 30% of staff, prioritising blood cancers programme over solid tumours","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxOZjJGclVYdGhNYnUwSGtSTHhjTUlDb2JUVGZRTTB0d2RuazZQdHRDYmdWWklnTUhuOUJrZk1FeTNwb3AzcDZMdjYzV3BNcEE4UWZLeTROTTA2MWdtdW9ZbGFHaWduaUdpbElBQ2JWWnhLN3lVX1dyNXdpXzVYZ2FtSFZCZmRWV2E0b284anQ3dkNDR3FJVVVhSEVsbDQ?oc=5","date":"2025-11-04","type":"pipeline","source":"The Business Journals","summary":"Biotech firm TScan slashes jobs, extends cash runway amid strategic realignment - The Business Journals","headline":"Biotech firm TScan slashes jobs, extends cash runway amid strategic realignment","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirgFBVV95cUxQNmxnRmo5bzYtQ0pjRDhtVllMamhSMjJBb0ZvYUNYUy1SMWNlSUNTSHA5VlNfZEh2MDFoVWl4UTdKRktoVVRwVHRHZjQ2QlV6NzF5Q3BJcGhlU3ViWk8xaFZ6dDFQeXktUDVvMGdxYk9yS1JxcnNLXzhvano4RFRTWnpyS2xodXZ2VGxZNzFqWWY4dmU0dEZaN056N0R5LVZCcFZkUUpOc0h5azVnY0E?oc=5","date":"2025-11-03","type":"trial","source":"Fierce Biotech","summary":"TScan lays off 30% of workforce, halts phase 1 solid tumor T-cell receptor trial - Fierce Biotech","headline":"TScan lays off 30% of workforce, halts phase 1 solid tumor T-cell receptor trial","sentiment":"negative"},{"url":"https://news.google.com/rss/articles/CBMi5wFBVV95cUxPa1p0M3lSSXd5dy1kZk5OX3pTUUtmQUVOM3ctM2hpcjcwRVBjOEhpTUQzaUtHY0xJc2FkTHVEcGN4ZjlWMW1TcUpyQVVmQlVxNjhMNEs0NnM0S0lCeGtQZ1ZydUJhbk85c09xMHlCXzN6bUNyREFXUG1wYmV3NXo1Y2hyZUZHX2gxVFZjSndvUTQ2UktoalpMYmh3ejFMdEZEVmZNb2o3TDhIYUw4aUdIcWpEYmkxbzZhRFBXQll6M0YwYUNCaFpfRmR5RHlmOGN0VGhWdUdCT1d2cTVLeVdlaFNvd0lZT2fSAewBQVVfeXFMTU01cEtocFhPWEFxdFNKSVI5TU8wcl9hT0ItT1Y1UmwtdmY0ZE5PY3FFdWM0WjAyOThuU2NfbmZVS3kwdGYwSmZReDUzeENwakxyYTdzV2JZSHBvUU1Ma2NNbmZSVWJldkJwSU00Zmh6elQ3REpudGFnQzBiTVo5ejZZRDVNWU8yT2RuMWExeDlMbV9KRjlhcG5MbXVwMXZWclRWZEhKM3JJWDIwcW1pel82NXVOUjJ3bkZ0WWpFQW9JV1pvZTFXeE42UW03MHVfa285bDN1andVM2Q0d0JCWUlXTjdvam93WnYtQUk?oc=5","date":"2025-07-11","type":"pipeline","source":"simplywall.st","summary":"Great week for TScan Therapeutics, Inc. (NASDAQ:TCRX) institutional investors after losing 73% over the previous year - simplywall.st","headline":"Great week for TScan Therapeutics, Inc. (NASDAQ:TCRX) institutional investors after losing 73% over the previous year","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE9tbFNfdG92bkhJQ1BtUU1EU0hNYzJwNWVyMUpfcEJpRXhnVWRxVU1PZHozeFJpc3k0YXd3SmFycm5UdWFHOEFueVdMY2RxbE5RUU8w?oc=5","date":"2025-04-25","type":"pipeline","source":"Stock Titan","summary":"TCRX Stock Price, News & Analysis - Stock Titan","headline":"TCRX Stock Price, News & Analysis","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}